High Resolution Retina Imaging

Overview

To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 30, 2023

Clinical Trial Outcome Measures

Primary Measures

  • Evolution of retina diseases
    • Time Frame: From date of inclusion until the date of last documented progression , assessed up to 5 years
    • Increase the clinical experience of using the rtx1 camera in various conditions with retinal impact

Participating in This Clinical Trial

Inclusion Criteria

  • Persons over 12 years of age, of both sexes, presenting with retinal pathologies. – Beneficiaries of the health insurance Exclusion Criteria:

  • Any abnormality preventing good quality OA imaging on both eyes – Major under guardianship or curatorship

Gender Eligibility: All

Minimum Age: 12 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Michel PAQUES, Principal Investigator, Centre Hospitalier National d’Ophtalmologie des Quinze-Vints
  • Overall Contact(s)
    • Tania RILCY, +33 140021126, trilcy@15-20.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.